These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19078231)

  • 1. Digital necrosis as an early manifestation of limited cutaneous systemic sclerosis.
    J Clin Rheumatol; 1997 Dec; 3(6):376-7. PubMed ID: 19078231
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers.
    Allanore Y; Borderie D; Meune C; Lemaréchal H; Weber S; Ekindjian OG; Kahan A
    Ann Rheum Dis; 2005 Mar; 64(3):481-3. PubMed ID: 15708899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.
    Nihtyanova SI; Brough GM; Black CM; Denton CP
    Ann Rheum Dis; 2008 Jan; 67(1):120-3. PubMed ID: 17660220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
    Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
    J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for the cutaneous manifestations of systemic sclerosis.
    Dutz J
    Skin Therapy Lett; 2000; 6(1):3-5. PubMed ID: 11027421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panniculitis-an unusual cutaneous manifestation of systemic sclerosis.
    Almeida MS; Lima SC; Carvalho LL; Almeida JV; Santos LG; Rolim JR; Rocha TE
    J Cutan Pathol; 2010 Nov; 37(11):1170-3. PubMed ID: 19615030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
    Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on the treatment of systemic scleroderma].
    Priollet P; Cazalis P; Valleteau de Moulliac M
    J Mal Vasc; 1987; 12(2):213-7. PubMed ID: 3295097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations.
    Scheja A; Wildt M; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2011 Nov; 40(6):457-61. PubMed ID: 21936615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Digital ulcers in systemic sclerosis].
    Prus V
    Reumatizam; 2010; 57(2):115-7. PubMed ID: 21875016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cutaneous manifestation of antiphospholipid antibody syndrome.
    DiFrancesco LM; Burkart P; Hoehn JG
    Ann Plast Surg; 2003 Nov; 51(5):517-22. PubMed ID: 14595191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal T cells in the blood of patients with systemic sclerosis.
    Marie I; Cordel N; Lenormand B; Hellot MF; Levesque H; Courtois H; Joly P
    Arch Dermatol; 2005 Jan; 141(1):88-9. PubMed ID: 15655151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extensive cutaneous necrosis as an initial manifestation of secondary antiphospholipid syndrome (APS)].
    Braz Ade S; Capriglione ML; Sarmento JF
    Acta Reumatol Port; 2010; 35(2):244-8. PubMed ID: 20711097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of an oral prostacyclin analog, beraprost sodium, on digital necrosis in systemic sclerosis. French Microcirculation Society Multicenter Group for the Study of Vascular Acrosyndromes.
    Vayssairat M
    J Rheumatol; 1999 Oct; 26(10):2173-8. PubMed ID: 10529135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulnar artery involvement in systemic sclerosis (scleroderma).
    Taylor MH; McFadden JA; Bolster MB; Silver RM
    J Rheumatol; 2002 Jan; 29(1):102-6. PubMed ID: 11824945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Galluccio F; Matucci-Cerinic M
    Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Takehara K; Sato S
    Ann Rheum Dis; 2004 May; 63(5):583-7. PubMed ID: 15082492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.